# Correction: Jannoo et al. Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide. Cancers 2023, 15, 2772

**Authors:** Riaz Jannoo, William Walker, Venkateswarlu Kanamarlapudi

PMC · DOI: 10.3390/cancers16051006 · Cancers · 2024-02-29

## Full-text entities

- **Genes:** IL13RA2 (interleukin 13 receptor subunit alpha 2) [NCBI Gene 3598] {aka CD213A2, CT19, IL-13R, IL13BP}
- **Diseases:** Cancers (MESH:D009369), Breast Cancer (MESH:D001943)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10930493/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10930493/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC10930493/full.md

---
Source: https://tomesphere.com/paper/PMC10930493